Skip to main content
. 2017 Apr 28;91(10):e02059-16. doi: 10.1128/JVI.02059-16

TABLE 5.

Effect of the CX4C mutation on memory response by CD4 and CD8 splenocytes

Groupa % cytokine-producing T cellsb
CD4
CD8
Total CD4
TMEM
TCM
Total CD8 TMEM TCM
T-bet IFN-γ Gata-3 IL-4 T-bet IFN-γ Gata-3 IL-4 T-bet IFN-γ Gata-3 IL-4
1 12 ± 0 9 ± 5 3 ± 1 23 ± 2 6 ± 2 20 ± 4 3 ± 0 7 ± 1 6 ± 1 9 ± 3 13 ± 2 12 ± 2 8 ± 1 3 ± 0 1 ± 0 3 ± 0 5 ± 1 2 ± 1 1 ± 0 6 ± 1 10 ± 2 6 ± 0 1 ± 0 4 ± 0
2 42 ± 4c 73 ± 3c 1 ± 0 2 ± 0c 22 ± 2c 90 ± 3c 1 ± 1 1 ± 0 28 ± 2c 82 ± 3c 2 ± 0c 2 ± 0c 25 ± 5c 19 ± 2c 0 ± 0 1 ± 0 27 ± 1c 12 ± 1c 0 ± 0 1 ± 0 37 ± 3c 35 ± 4c 0 ± 0 0 ± 0
3 9 ± 3 19 ± 3 1 ± 0 39 ± 3 34 ± 3 16 ± 2 2 ± 0 34 ± 6 27 ± 2 13 ± 3 5 ± 1 37 ± 7 9 ± 2 8 ± 1 1 ± 0 2 ± 0 10 ± 1 5 ± 1 1 ± 0 12 ± 0 16 ± 2 4 ± 1 1 ± 0 3 ± 0
4 58 ± 9c 67 ± 5c 0 ± 0 6 ± 0c 91 ± 4c 97 ± 3c 0 ± 0 7 ± 1c 84 ± 3c 88 ± 3c 2 ± 0 6 ± 0c 51 ± 1c 45 ± 1c 0 ± 0 0 ± 0 35 ± 1c 24 ± 2c 0 ± 0 1 ± 0c 55 ± 0c 44 ± 7c 0 ± 0 1 ± 0
5 49 ± 5c 66 ± 5c 0 ± 0 1 ± 0 24 ± 1c 92 ± 1c 0 ± 0 1 ± 0 29 ± 1c 83 ± 1c 2 ± 1 2 ± 0 29 ± 3c 22 ± 4c 0 ± 0 1 ± 0 24 ± 2c 13 ± 0c 0 ± 0 1 ± 0 36 ± 2c 36 ± 3c 0 ± 0 0 ± 0
6 54 ± 1c 72 ± 3c 0 ± 0 5 ± 0 89 ± 3c 91 ± 2c 0 ± 0 6 ± 0 86 ± 1c 88 ± 1c 1 ± 0 5 ± 0 51 ± 0c 44 ± 2c 0 ± 0 0 ± 0 36 ± 2c 22 ± 1c 0 ± 0 1 ± 1 55 ± 4c 45 ± 3c 0 ± 0 1 ± 0
7 1 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 1 ± 0 0 ± 0 0 ± 0 1 ± 1 1 ± 1 0 ± 0 0 ± 0 0 ± 0 1 ± 1 0 ± 0 0 ± 0 0 ± 0 2 ± 0 0 ± 0 0 ± 0 2 ± 1 1 ± 0 0 ± 0 0 ± 0
a

1, wt A2; 2 A2-CX4C; 3, wt r19F; 4, r19F-CX4C; 5, wt A2 plus F(ab′)2 131-2G; 6, wt r19F plus F(ab′)2 131-2G; 7, mock infected.

b

Frequencies of T-bet and IFN-γ or Gata-3 and IL-4 secretion in CD4, TMEM, or TCM T cells and CD8, TMEM or TCM T cells from peptide stimulated spleenocytes, 75 days p.i. Mice were challenged intranasally with the indicated virus or virus plus G MAb 131-2G (F(ab′)2 administered intraperitoneally 2 days before challenge or mock infected, as described in Materials and Methods. Spleens were harvested 75 days p.i. and processed, and splenocytes were stimulated with an RSV-specific CD4 or CD8 peptide or ovalbumin (Ova) control peptide. (A) CD4 T cell response to RSV-specific CD4 peptide or Ova control peptide. (B) CD8 T cell response to an RSV-specific CD8 peptide or Ova control peptide. The values for Ova stimulation are not shown but were similar to the values for mock-infected mice stimulated with the respective RSV peptide. The values (±SEM) are from 5 mice per group. TMEM, effector memory cells; TCM, central memory cells.

c

Significant difference (P ≤ 0.001), as determined by one-way ANOVA and post hoc Tukey's HSD test.